updates in theraupetics for Parkinson's disease

[Farooqji]

The speaker was Gaurav Chattree, MD, movement disorder specialist at Stanford. He addressed the "phase 3" or "almost phase 3" research pipeline for disease-modification treatments and for symptomatic therapies

m.youtube.com/watch?v=yUt1k...(Not working as expected?)

[DIY4PD-GBA]

Thank you for posting this.

[Zardoz]

Really nothing new here. Cough syrup, exenatide... Peter Tass hit a speed bump and Dr. Chattree is down on stem cell treatment.

[Farooqji in reply to Zardoz]

yes, but he has explained it in a very self explanatory way. Obviously there no major breakthrough so far on the horizon except what we already know

He has not mentioned the Japanese and Chinese stem cell trials. He has also missed Hope biosciences trial. There is much more going on on stem cell front

[jeffreyn in reply to Farooqji]

For me, one of Dr Chattree's "thoughts" on the stem-cell trials was an eye opener (second last slide).

"at 5 to 10 years post implantation, I suspect we will see difficult to control dyskinesias"

Wow, I had not heard that before. At least not in relation to the current stem-cell trials.

[Farooqji]

ctxt.io/2/AAAoCngeFg